Blood Component Therapies
Buyers
Value
£164,050
Suppliers
Classifications
- Research and development services and related consultancy services
Tags
- award
Submission Deadline
1 year ago
Published
11 months ago
Description
The Institution will provide the required laboratory facilities and technical support in order for the Principal Investigator to conduct research in order to answer the following objectives: a. Evaluate clot structure and stability in clots formed from whole blood vs. red blood cell, plasma and platelet component therapy b. How do additive and storage solutions used to stabilise red blood cell and platelet component therapies alter clot structure and stability? c. How does cold or warm storage of blood products alter clot structure and stability
Similar Contracts
Open
Published 4 days ago
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline complete
Complete